The vital signs monitoring devices market focuses on medical devices used to measure essential body functions such as heart rate, blood pressure, respiratory rate, temperature, and oxygen saturation. These devices play a critical role in patient care, enabling early detection of health issues and continuous monitoring in hospitals, clinics, and home settings. The market is growing steadily due to the rising prevalence of chronic diseases, an aging global population, and increased demand for remote and real-time health monitoring. Technological advancements—such as wearable monitors and smart health systems—are further enhancing device accuracy and usability. While North America leads in market share, the Asia-Pacific region is witnessing rapid growth due to expanding healthcare access and increasing awareness of preventive care.
According to Fortune Business Insights, the global vital sign monitoring devices market was valued at USD 5.87 billion in 2024 and is projected to grow from USD 6.27 billion in 2025 to USD 10.47 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.6% during the forecast period. In 2024, North America dominated the market with a 42.47% share.
Top Companies in the Market
- Masimo (U.S.)
- OMRON HEALTHCARE Co., Ltd. (Japan)
- Medtronic (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- GE Healthcare (U.S.)
- Contec Medical Systems Co. Ltd. (China)
- Nonin (U.S.)
- SunTech Medical, Inc. (U.S.)
Key Industry Developments
- April 2024: GE Healthcare received U.S. FDA approval for its Portrait VSM vital signs monitor, offering clinicians accurate and continuous monitoring of patient vital signs to support timely clinical decisions.
Market Drivers
- Rising Prevalence of Chronic Diseases: The increasing incidence of lifestyle-related chronic disorders, such as hypertension and diabetes, is propelling the demand for vital sign monitoring devices.
- Technological Advancements: Integration of artificial intelligence and machine learning in monitoring devices enhances accuracy and enables remote patient monitoring, driving market growth.
- Growing Geriatric Population: The aging population is more susceptible to chronic conditions, necessitating continuous monitoring and contributing to market expansion.
Market Restraints
- High Cost of Devices: The substantial cost associated with advanced monitoring devices may limit adoption, especially in emerging economies.